These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 21490800)

  • 1. Enzymatically modified low-density lipoprotein is recognized by c1q and activates the classical complement pathway.
    Arlaud GJ; Biro A; Ling WL
    J Lipids; 2011; 2011():376092. PubMed ID: 21490800
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complement protein C1q recognizes enzymatically modified low-density lipoprotein through unesterified fatty acids generated by cholesterol esterase.
    Biro A; Ling WL; Arlaud GJ
    Biochemistry; 2010 Mar; 49(10):2167-76. PubMed ID: 20166680
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modified low density lipoproteins differentially bind and activate the C1 complex of complement.
    Biró A; Thielens NM; Cervenák L; Prohászka Z; Füst G; Arlaud GJ
    Mol Immunol; 2007 Feb; 44(6):1169-77. PubMed ID: 16938346
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Innate immune proteins C1q and mannan-binding lectin enhance clearance of atherogenic lipoproteins by human monocytes and macrophages.
    Fraser DA; Tenner AJ
    J Immunol; 2010 Oct; 185(7):3932-9. PubMed ID: 20833838
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beta-amyloid fibrils activate the C1 complex of complement under physiological conditions: evidence for a binding site for A beta on the C1q globular regions.
    Tacnet-Delorme P; Chevallier S; Arlaud GJ
    J Immunol; 2001 Dec; 167(11):6374-81. PubMed ID: 11714802
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High molecular weight non-immunoglobulin salivary agglutinins (NIA) bind C1Q globular heads and have the potential to activate the first complement component.
    Boackle RJ; Connor MH; Vesely J
    Mol Immunol; 1993 Feb; 30(3):309-19. PubMed ID: 8433709
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies on the interactions between C-reactive protein and complement proteins.
    Bíró A; Rovó Z; Papp D; Cervenak L; Varga L; Füst G; Thielens NM; Arlaud GJ; Prohászka Z
    Immunology; 2007 May; 121(1):40-50. PubMed ID: 17244159
    [TBL] [Abstract][Full Text] [Related]  

  • 8. C1 Complex: An Adaptable Proteolytic Module for Complement and Non-Complement Functions.
    Lu J; Kishore U
    Front Immunol; 2017; 8():592. PubMed ID: 28596769
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rat polymeric IgA binds C1q, but does not activate C1.
    Hiemstra PS; Rits M; Gorter A; Stuurman ME; Hoekzema R; Bazin H; Vaerman JP; van Es LA; Daha MR
    Mol Immunol; 1990 Sep; 27(9):867-74. PubMed ID: 2215479
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of immune complexes in the activation of the first component of human complement.
    Ziccardi RJ
    J Immunol; 1984 Jan; 132(1):283-8. PubMed ID: 6317744
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [An alternative hypothesis of the pathogenesis of atherosclerosis].
    Bhakdi S
    Herz; 1998 May; 23(3):163-7. PubMed ID: 9646097
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Highly specific inhibition of C1q globular-head binding to human IgG: a novel approach to control and regulate the classical complement pathway using an engineered single chain antibody variable fragment.
    Hwang HY; Duvall MR; Tomlinson S; Boackle RJ
    Mol Immunol; 2008 May; 45(9):2570-80. PubMed ID: 18313756
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The distortive mechanism for the activation of complement component C1 supported by studies with a monoclonal antibody against the "arms" of C1q.
    Hoekzema R; Martens M; Brouwer MC; Hack CE
    Mol Immunol; 1988 May; 25(5):485-94. PubMed ID: 3261834
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Possible protective role for C-reactive protein in atherogenesis: complement activation by modified lipoproteins halts before detrimental terminal sequence.
    Bhakdi S; Torzewski M; Paprotka K; Schmitt S; Barsoom H; Suriyaphol P; Han SR; Lackner KJ; Husmann M
    Circulation; 2004 Apr; 109(15):1870-6. PubMed ID: 15037531
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibody-independent activation of C1. II. Evidence for two classes of nonimmune activators of the classical pathway of complement.
    Peitsch MC; Kovacsovics TJ; Tschopp J; Isliker H
    J Immunol; 1987 Mar; 138(6):1871-6. PubMed ID: 3029223
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The extracellular matrix and inflammation: fibromodulin activates the classical pathway of complement by directly binding C1q.
    Sjöberg A; Onnerfjord P; Mörgelin M; Heinegård D; Blom AM
    J Biol Chem; 2005 Sep; 280(37):32301-8. PubMed ID: 16046396
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potential protective role of apoprotein J (clusterin) in atherogenesis: binding to enzymatically modified low-density lipoprotein reduces fatty acid-mediated cytotoxicity.
    Schwarz M; Spath L; Lux CA; Paprotka K; Torzewski M; Dersch K; Koch-Brandt C; Husmann M; Bhakdi S
    Thromb Haemost; 2008 Jul; 100(1):110-8. PubMed ID: 18612545
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Specific inhibition of the classical complement pathway with an engineered single-chain Fv to C1q globular heads decreases complement activation by apoptotic cells.
    Duvall MR; Hwang HY; Boackle RJ
    Immunobiology; 2010 May; 215(5):395-405. PubMed ID: 19586684
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunohistochemical demonstration of enzymatically modified human LDL and its colocalization with the terminal complement complex in the early atherosclerotic lesion.
    Torzewski M; Klouche M; Hock J; Messner M; Dorweiler B; Torzewski J; Gabbert HE; Bhakdi S
    Arterioscler Thromb Vasc Biol; 1998 Mar; 18(3):369-78. PubMed ID: 9514405
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surfactant protein A regulates complement activation.
    Watford WT; Wright JR; Hester CG; Jiang H; Frank MM
    J Immunol; 2001 Dec; 167(11):6593-600. PubMed ID: 11714829
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.